Skip to main content

Year: 2024

Awilco Drilling PLC: Minutes from Extraordinary General Meeting

An Extraordinary General Meeting of Awilco Drilling PLC was held Friday 25 October 2024 at 11:00am (UK time), at the Company’s registered office, Suite 1, 7th Floor, 50 Broadway, London, SW1H 0BL, United Kingdom. The resolution set out in the Meeting Notice was duly passed. The signed minutes of meeting are attached hereto. The Meeting Notice is available on our website www.awilcodrilling.com, under ‘Investor Relations/General Meetings’. Aberdeen, 25 October 2024 For further information please contact: Eric Jacobs, Interim CEOPhone: +47 9529 2271 Cathrine Haavind, Investor RelationsPhone: +47 9342 8464Email: ch@awilcodrilling.com This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentAWDR EGM Meeting Minutes 25 October 2024

Continue reading

ROCKWOOL strengthens position in UK market with acquisition of Wetherby Building Systems Ltd.

LONDON, Oct. 25, 2024 (GLOBE NEWSWIRE) — Denmark-based ROCKWOOL Group is pleased to announce it is acquiring Wetherby Building Systems Ltd. The acquisition marks an important milestone in ROCKWOOL’s quest to expand its façade expertise in the UK. Wetherby Building Systems Ltd, headquartered in Golborne, Greater Manchester, is a leading UK supplier for external thermal insulation composite systems (ETICS). Wetherby will become part of the ROCKWOOL Wall Systems organisation under the new designation Wetherby Wall Systems, joining counterpart organisations that include ETICS specialists HECK Wall Systems in Germany and FAST Wall Systems in Poland. Importance of the acquisitionThe energy efficiency of buildings plays an important role in meeting the UK’s commitment to reaching net zero by 2050. ROCKWOOL Group CEO Jes Munk...

Continue reading

Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR Conference

Presentations highlight key preclinical data that support investigational new drug application (IND) submissions for ZW220 in 1H and ZW251 in 2H in 2025VANCOUVER, British Columbia, Oct. 25, 2024 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced new preclinical data for Zymeworks’ antibody-drug conjugate (ADC) candidates ZW220 and ZW251 in presentations at the European Organisation for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research (EORTC-NCI-AACR) Conference taking place in Barcelona on October 23-25, 2024. “We are thrilled to present preclinical data for ZW220 and ZW251 at the...

Continue reading

Lotus Technology Honored as Highly Commends at Reuters Sustainability Awards 2024

NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) — Lotus Technology Inc. (“Lotus Tech” or “the Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, has been bestowed with the Highly Commends honor at the Reuters Sustainability Awards 2024 in the Business Transformation category. The Reuters Sustainability Awards, now in its 14th year, stand as the world’s premier awards celebrating leadership in sustainable business. With over 700 global entrants this year, 30 winners were selected across 17 categories. Notably, Lotus Tech is the sole winner from the automotive industry. The Business Transformation Award recognizes companies taking crucial steps to transform their business models in line with a clean, resilient, and just future. Lotus Tech’s win is a testament to its comprehensive sustainability...

Continue reading

Vine Hill Capital Investment Corp. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on October 28, 2024

Fort Lauderdale, Florida, Oct. 25, 2024 (GLOBE NEWSWIRE) — Vine Hill Capital Investment Corp. (Nasdaq: VCICU) (the “Company”), a special purpose acquisition company, today announced that, commencing on October 28, 2024, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units. The Ordinary Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “VCIC” and “VCICW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “VCICU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have...

Continue reading

RadNet, Inc. Announces Date of its Third Quarter 2024 Financial Results Conference Call

LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its third quarter 2024 financial results on Monday, November 11, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are invited to listen to RadNet’s conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1691984&tp_key=8cbf05cc88. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers,...

Continue reading

Verkkokauppa.com Oyj – Managers’ Transactions – Henrik Pankakoski

Verkkokauppa.com Oyj – Managers’ Transactions – Henrik Pankakoski Verkkokauppa.com Oyj MANAGERS’ TRANSACTIONS 25 October 2024 at 12:00 EEST On 4 April 2024, the Annual General Meeting of Verkkokauppa.com Oyj resolved that the annual fee of the company’s Board of Directors is paid in four equal instalments in Verkkokauppa.com shares either purchased from the market or alternatively by using treasury shares held by the company. In accordance with the resolution, a total of 2,561 shares have been transferred to Henrik Pankakoski as follows: Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Henrik PankakoskiPosition: Member of the Board/Deputy member Issuer: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75Notification...

Continue reading

Verkkokauppa.com Oyj – Managers’ Transactions – Irmeli Rytkönen

Verkkokauppa.com Oyj – Managers’ Transactions – Irmeli Rytkönen Verkkokauppa.com Oyj MANAGERS’ TRANSACTIONS 25 October 2024 at 12:00 EEST On 4 April 2024, the Annual General Meeting of Verkkokauppa.com Oyj resolved that the annual fee of the company’s Board of Directors is paid in four equal instalments in Verkkokauppa.com shares either purchased from the market or alternatively by using treasury shares held by the company. In accordance with the resolution, a total of 2,561 shares have been transferred to Irmeli Rytkönen as follows: Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Irmeli RytkönenPosition: Member of the Board/Deputy member Issuer: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75Notification...

Continue reading

Revolution Medicines Presents Initial Data from RMC-9805 Monotherapy Study in Patients with Advanced Pancreatic Ductal Adenocarcinoma

First clinical results for RMC-9805, a RAS(ON) G12D-selective inhibitor, demonstrate encouraging tolerability and antitumor activity in patients with PDAC Investor webcast to be held Friday, October 25 at 12:00 p.m. Eastern Time (ET) REDWOOD CITY, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced preliminary safety and antitumor data for RMC-9805, its RAS(ON) G12D-selective inhibitor, in patients with previously treated pancreatic ductal adenocarcinoma (PDAC). These initial results were presented during the late-breaking oral session at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona on October 25, 2024. “We are pleased to report the first clinical data...

Continue reading

InterDigital Engineers Awarded SMPTE 2024 Journal Certificate of Merit for Energy-Aware Pixel Value Reduction Research

WILMINGTON, Del., Oct. 25, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, announced that research from InterDigital’s Video Lab was recognized with the Society of Motion Picture and Television Engineers (SMPTE) Journal Certificate of Merit. The research paper, titled “Pixel Value Adjustment to Reduce the Energy Requirements of Display Devices,” was written by InterDigital engineers Erik Reinhard, Claire-Hélène Demarty, and Laurent Blondé, and introduces InterDigital’s innovative technique of pixel value reduction (PVR) to optimize pixel brightness on device displays to reduce the energy consumed without compromising the visual quality. SMPTE is a global society of more than 5,000 creative professionals, media technologists, and engineers that transform...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.